Abstract
Pharmaceutical pricing policies are an important component of the pharmaceutical policy environment given their role in the financial sustainability of the health system. This chapter outlines several key domains of the pharmaceutical policy environment within which pharmaceutical pricing policies exist. Every country has its unique mix of laws, regulations, policies, management strategies and support systems for pharmaceutical products. These guide provisions relating to the manufacturing, importing, marketing, labeling, distribution, prescribing, dispensing, and pricing of pharmaceutical products.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aaserud M, Dahlgren AT, Kosters JP, Oxman AD, Ramsay C, Sturm H (2006) Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev 2, CD005979
Austvoll-Dahlgren A, Aaserud M, Vist G et al (2008) Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev 1, CD007017
Green CJ, Maclure M, Fortin PM, Ramsay CR, Aaserud M, Bardal S (2010) Pharmaceutical policies: effects of restrictions on reimbursement. Cochrane Database Syst Rev 8, CD008654
Hoebert JM, van Dijk L, Mantel-Teeuwisse AK, Leufkens HG, Laing RO (2013) National medicines policies—a review of the evolution and development processes. J Pharm Policy Pract 6:5
Lu CY, Ross-Degnan D, Soumerai SB, Pearson SA (2008) Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature—2001–2007. BMC Health Serv Res 8:75
Management Sciences for Health (2012) MDS-3: managing access to medicines and health technologies. Management Sciences for Health, Arlington
Organisation for Economic Cooperation and Development (2008) Pharmaceutical pricing policies in a global market. Organisation for Economic Cooperation and Development, Paris
Schweitzer S (1997) Pharmaceutical economics and policy. Oxford University Press, New York
Smith RD, Correa C, Oh C (2009) Trade, TRIPS, and pharmaceuticals. Lancet 373(9664):684–691
Sturm H, Austvoll-Dahlgren A, Aaserud M et al (2007) Pharmaceutical policies: effects of financial incentives for prescribers. Cochrane Database Syst Rev 3, CD006731
World Health Organization (2001) How to develop and implement a national drug policy, 2nd edn. WHO, Geneva
World Health Organization (2004) WHO policy perspectives on medicines: equitable access to essential medicines: a framework for collective action. WHO, Geneva
World Health Organization (2011) The world medicines situation, 3rd edn. WHO, Geneva
World Health Organization (2012) The pursuit of responsible use of medicines: sharing and learning from country experiences. WHO, Geneva
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lu, C.Y. (2015). The Pharmaceutical Policy Environment and Pharmaceutical Pricing Policies. In: Babar, ZUD. (eds) Pharmaceutical Prices in the 21st Century. Adis, Cham. https://doi.org/10.1007/978-3-319-12169-7_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-12169-7_22
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-12168-0
Online ISBN: 978-3-319-12169-7
eBook Packages: Business and EconomicsEconomics and Finance (R0)